Search
for

    Sort by

    Research 121–150 of 1000+

    1. A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata Journal of health economics and outcomes research · 2026
    2. Current and future pharmacotherapy for alopecia areata Expert opinion on orphan drugs · 2015 · 2 citations
    3. Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis The Journal of Dermatology · 2024 · 7 citations
    4. Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway Journal of Molecular Cell Biology · 2023 · 6 citations
    5. Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation Current Issues in Molecular Biology · 2024
    6. Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib Clinical and translational science · 2016 · 10 citations
    7. Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream Pharmaceutics · 2021 · 24 citations
    8. Under Development JAK Inhibitors for Dermatologic Diseases Mediterranean Journal of Rheumatology · 2020 · 14 citations
    9. Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025
    10. Use of Jak Inhibitors in the Treatment of Alopecia Areata Serbian Journal of Dermatology and Venerology · 2026
    11. Targeting the Janus Kinase Family in Autoimmune Skin Diseases Frontiers in Immunology · 2019 · 124 citations
    12. JAK Inhibitors for Treatment of Alopecia Areata 2018 · 63 citations
    13. Mimosine Dipeptide Enantiomsers: Improved Inhibitors against Melanogenesis and Cyclooxygenase Molecules · 2015 · 25 citations
    14. Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway Indian Dermatology Online Journal · 2023
    15. Emerging Topical and Systemic JAK Inhibitors in Dermatology Frontiers in Immunology · 2019 · 277 citations
    16. JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology Medicina · 2026
    17. Inibidores das Janus Associated Kinases na Terapêutica Farmacológica 2016 · 1 citations
    18. Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients The Journal of Dermatology · 2025
    19. Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes Cureus · 2023
    20. Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis Journal of Investigative Dermatology · 2014 · 185 citations
    21. Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARα and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways Journal of Cellular Biochemistry · 2005 · 24 citations
    22. Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome Endocrinology · 2016 · 11 citations
    23. Referee report. For: Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment [version 3; peer review: 2 approved] Faculty of 1000 Research Ltd · 2021
    24. Cell wall-associated ROOT HAIR SPECIFIC 10, a proline-rich receptor-like kinase, is a negative modulator of Arabidopsis root hair growth Journal of Experimental Botany · 2016 · 33 citations
    25. Which plant for which skin disease? Part 2: Dermatophytes, chronic venous insufficiency, photoprotection, actinic keratoses, vitiligo, hair loss, cosmetic indications Journal der Deutschen Dermatologischen Gesellschaft · 2010 · 19 citations
    26. Discoid lupus erythematosus successfully treated with deucravacitinib JAAD Case Reports · 2024 · 13 citations
    27. Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population Dermatologic Therapy · 2022 · 2 citations
    28. Botryococcus terribilis Ethanol Extract Exerts Anti-inflammatory Effects on Murine RAW264 Cells International Journal of Molecular Sciences · 2023 · 1 citations
    29. Inhibition of T-cell activity in alopecia areata: recent developments and new directions Frontiers in immunology · 2023 · 4 citations
    30. The JAK/STAT signaling pathway: from bench to clinic Signal Transduction and Targeted Therapy · 2021 · 489 citations